You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

sHLH

Showing 1 - 14 of 14
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Secondary Hemophagocytic Lymphohistiocytosis (sHLH) Trial in Worldwide (ELA026)

Recruiting
  • Secondary Hemophagocytic Lymphohistiocytosis (sHLH)
  • Innsbruck, Austria
  • +9 more
Oct 24, 2022

Macrophage Activation Syndrome, Lymphohistiocytosis, Hemophagocytic, Arthritis, Juvenile Trial in Worldwide (Emapalumab)

Completed
Has Results
  • Macrophage Activation Syndrome
  • +3 more
  • Cincinnati, Ohio
  • +4 more
May 16, 2022

COVID-19 Prospective Cohort for Identification of Secondary HLH

Unknown status
  • COVID
    • München, Bavaria, Germany
      Department of nephrology, Klinikum rechts der Isar
    Apr 11, 2020

    Macrophage Activation Syndrome, Secondary Hemophagocytic Lymphohistiocytosis, Still Disease Trial in Worldwide (Emapalumab)

    Recruiting
    • Macrophage Activation Syndrome
    • +6 more
    • Birmingham, Alabama
    • +41 more
    Jan 3, 2023

    Hematologic Malignancy Trial in Bologna

    Recruiting
    • Hematologic Malignancy
      • Bologna, Italy
        Programma Dipartimentale Terapie Cellulari Avanzate
      Apr 17, 2023

      Novel Factors Leading to Activated Macrophage Expansion in

      Active, not recruiting
      • Covid19
      • SARS-CoV-2 Infection
      • Soton hyperinflammation score
      • HScore
      • Southampton, Hampshire, United Kingdom
        University Hospitals Southampton NHS Foundation Trust
      May 25, 2021

      COVID-19 Acute Respiratory Distress Syndrome, Cytokine Release Syndrome, Pulmonary Fibrosis Trial (cyclosporine)

      Not yet recruiting
      • COVID-19 Acute Respiratory Distress Syndrome
      • +2 more
      • (no location specified)
      Jul 26, 2021

      Ivermectin, Aspirin, Dexamethasone and Enoxaparin as Treatment

      Completed
      Has Results
      • Severe Acute Respiratory Syndrome
      • Ventilation Pneumonitis
      • Ivermectin 5 MG/ML oral solution, Aspirin 250 mg tablets
      • +2 more
      • Buenos Aires, Argentina
        Hospital Eurnekian
      Oct 8, 2020

      SARS-CoV 2 Trial in Boston, Newton (Tocilizumab, Placebos)

      Completed
      Has Results
      • SARS-CoV 2
      • Boston, Massachusetts
      • +2 more
      Jul 23, 2021

      COVID-19 Hyperinflammation Syndrome: Protocol forRapidly

      Unknown status
      • COV-HI
      • +2 more
        • Leeds, United Kingdom
        • +4 more
        May 11, 2020

        COVID-19 Trial in Phoenix, Baltimore, New York (Clazakizumab 25 mg, Clazakizumab 12.5 mg, Placebo)

        Completed
        Has Results
        • COVID-19
        • Clazakizumab 25 mg
        • +2 more
        • Phoenix, Arizona
        • +2 more
        Jun 10, 2022

        COVID-19 Pnemonia Trial in Spain (Anakinra 149 MG/ML Prefilled Syringe [Kineret])

        Completed
        • COVID-19 Pnemonia
        • Anakinra 149 MG/ML Prefilled Syringe [Kineret]
        • Zaragoza, Aragón, Spain
        • +11 more
        May 27, 2021

        Covid19, Ketogenic Dieting Trial in Genova (Ketogenic diet)

        Recruiting
        • Covid19
        • Ketogenic Dieting
        • Ketogenic diet
        • Genova, Italy
          Samir Giuseppe Sukkar
        Sep 28, 2020

        COVID, Pneumonia Trial in Roma

        Unknown status
        • COVID
        • Pneumonia
          • Roma, Italy
            Massimo Montalto
          Apr 29, 2020